Highest risk seen for those with both physical frailty and depression; significant additive interaction also seen.

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.

Lower risk for foot disease driven by lower risk for neuropathy for new users of SGLT-2 inhibitors versus GLP-1 receptor agonists.

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

(HealthDay News) — Financial strain and food insecurity are drivers of accelerated biological heart aging, according to a study published in the December issue of the Mayo Clinical Proceedings.

Investigators compared the risk of cancer onset in patients with lupus nephritis treatedwith calcineurin inhibitors vs ...

Aggressive renal cell carcinoma cases are increasing among younger adults aged 20 to 39 years in the United States.

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

Comparable and high THC-to-CBD ratio products may result in small improvements in pain and increase in common adverse events.

Recommendations include use of ACE-I or ARB to slow CKD progression in patients with hypertension and albuminuria.

Lower number of hospitalizations for any indication and serious adverse events with semaglutide for those with CVD, overweight or obesity.

In 2025, the number of all students enrolled in medical school reached 100,723 — a significant milestone for the future of ...